CM
CUE icon

Caption Management’s Cue Biopharma CUE Stock Holding History

Caption Management’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-467
Closed -$37K – 1290
2023
Q4 		$37K Hold
467
– – ﹤0.01% 1232
2023
Q3 		$32.2K Buy
+467
New +$45.6K ﹤0.01% 1206
2021
Q4 		– Sell
-907
Closed -$396K – 1659
2021
Q3 		$396K Hold
907
– – ﹤0.01% 1247
2021
Q2 		$316K Buy
+907
New +$352K ﹤0.01% 1125

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Caption Management's CUE Position: Q1 2024 in Review

Caption Management sold out of Cue Biopharma (CUE) in Q1 2024, closing a stake of 467 shares — an estimated $37K sold.

Caption Management first reported a position in CUE in Q2 2021 and held it in 4 quarters. The position peaked at $396K in Q3 2021. 74 funds tracked by Wall St. Rank hold CUE as of Q1 2024.

  • Caption Management reported no remaining Cue Biopharma position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 467 Cue Biopharma shares in Q1 2024, an estimated $37K.
  • Caption Management first reported a position in Cue Biopharma in Q2 2021 and held it in 4 quarters.
  • Caption Management's Cue Biopharma position peaked at $396K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.